Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro(R) (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be launched in Thailand at the end of May 2025. Zuellig Pharma holds the marketing authorization for Mounjaro(R) (tirzepatide) in Thailand, having been granted the distribution and promotion rights for the medicine by Eli Lilly and Company this year. Mounjaro(R) (tirzepatide) is a once-weekly
World teams up with 11 leading partners to combat bots and scammers, building a safer digital future for Thailand
—
Tools for Humanity (TFH), the technolo...
Dusit Thani Public Company Limited enters final stage of strategic roadmap to unlock value
—
Company targets total revenue growth rate of 25-30% in 2025. ...
ONYX Hospitality Group Unveils 2025 Strategic Plan Aiming to Lead ASEAN Hospitality, Launch ONYXRT REIT, and Strengthen Core Brands
—
"ONYX Hospitality Gr...
MSC Received Dual Recognition from Veeam Software at 2025 Partner Appreciation Event
—
Metro Systems Corporation Public Company Limited (MSC), a leading c...
Her Royal Highness Princess Maha Chakri Sirindhorn Grants Audience to Bangchak's Presentation of Mobile Blood Donation Vehicle
—
On June 5, 2025, Her Roya...
SiS Distribution (Thailand) PCL Welcomes Investors for Business Visit and Vision Sharing Session
—
SiS Distribution (Thailand) Public Company Limited (SiS...
Bangchak Retail Honored for Driving Efforts to Reduce Single-Use Plastics on World Environment Day 2025
—
Mr. Yosathorn Aranyanart, Managing Director of B...
SiS Recognized with Top Distributor Performance Award by Veeam, Underscoring Leadership in Enterprise Data Resilience and Cybersecurity in Thailand
—
SiS Distrib...
BSRC Supports "Future City" Knowledge-Enhancing Exhibition at Space Inspirium
—
Dr. Bowornsak Wanichkul, Vice President, Government Relations & Sustainabi...
Thai Coconut Aims for Global Beverage Innovation Leadership with Business Transformation; New Products Unveiled at THAIFEX - Anuga Asia 2025
—
Thai Coconu...
ซิลลิค ฟาร์มา เปิดตัวนวัตกรรมยาใหม่สำหรับรักษาโรคอ้วนและโรคเบาหวานในประเทศไทย มอนจาโร (เทอเซพาไทด์) จะมาถึงไทยในปลายเดือนพฤษภาคม 2568
—
ซิลลิค ฟาร์มา (Zue...
WHA Congratulates CHANG-AN on the Official Opening of Its First Overseas NEV Manufacturing Plant in Thailand at WHA Eastern Seaboard Industrial Estate 4
—
Mr. Pajongw...
Bangchak Recognized with Two Prestigious Global Sustainability Awards from S&P Global
—
Top 1% "No. 1" Ranking and "Industry Mover" Title Highlight Ou...
Metro Systems Corporation "MSC" Annual General Meeting Year 2025
—
Metro Systems Corporation Public Company Limited (MSC) held the Annual General Meeting ...
RML Announces Q1/2025 Performance, Reaffirms Turnaround Target Under Transformation Strategy
—
RML reported a 148%* year-on-year increase in total revenue...
B.Grimm Power Announces 51.6% Increase in Q1 2025 Profit
—
Advancing Industrial User Expansion and COD of Renewable Energy Projects Dr. Harald Link, Group...
Bangchak Reports Strong Q1/2025 Results Resilient Performance Amid Global Challenges, Driven by Synergy and Future Energy Innovation
—
Bangchak Group kick...
BSRC Advances Youth Development in STEM Through Support of GISTDA Space Camp
—
Dr. Nongluk Chawankul, Vice President, Refinery Business Enablement of a Pu...
MSC reveled Business Performance on Opportunity Day Year End 2024
—
Mr. Suradet Lertthammajak, Executive Director of Metro Systems Corporation Public Comp...